272 related articles for article (PubMed ID: 24924391)
21. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.
Gerolami R; Uch R; Jordier F; Chapel S; Bagnis C; Bréchot C; Mannoni P
Cancer Gene Ther; 2000 Sep; 7(9):1286-92. PubMed ID: 11023202
[TBL] [Abstract][Full Text] [Related]
23. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
24. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
25. Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer.
Zhou BY; Ye Z; Chen G; Gao ZP; Zhang YA; Cheng L
Stem Cells; 2007 Mar; 25(3):779-89. PubMed ID: 17158240
[TBL] [Abstract][Full Text] [Related]
26. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
27. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral transduction of microglial cells.
Balcaitis S; Weinstein JR; Li S; Chamberlain JS; Möller T
Glia; 2005 Apr; 50(1):48-55. PubMed ID: 15625717
[TBL] [Abstract][Full Text] [Related]
31. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
32. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
[TBL] [Abstract][Full Text] [Related]
33. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
34. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
35. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.
Ma Y; Ramezani A; Lewis R; Hawley RG; Thomson JA
Stem Cells; 2003; 21(1):111-7. PubMed ID: 12529558
[TBL] [Abstract][Full Text] [Related]
36. Multiple platforms of a HIV-2 derived lentiviral vector for expanded utility.
Chande AG; Raina S; Dhamne H; Kamat RH; Mukhopadhyaya R
Plasmid; 2013 Jan; 69(1):90-5. PubMed ID: 23159456
[TBL] [Abstract][Full Text] [Related]
37. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
Ogueta SB; Yao F; Marasco WA
Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
[TBL] [Abstract][Full Text] [Related]
38. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
39. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes.
Osti D; Marras E; Ceriani I; Grassini G; Rubino T; Viganò D; Parolaro D; Perletti G
J Virol Methods; 2006 Sep; 136(1-2):93-101. PubMed ID: 16690138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
